TherapeuticsMD (TXMD) Reports Q2 EPS of $0.05
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Join SI Premium – FREE
TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of $0.05.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- IONQ Inc (IONQ) 5K contracts of September 25 weekly 45 calls as share price up 4.7%
- Teradyne (TER) 5300 contracts of October 30 weekly calls active, share price down 2.6%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
